Pharma Bro Martin Shkreli Is Diligently At Work On A Big Second Act From His Prison Cell

With the help of a contraband smartphone, disgraced pharma executive Martin Shkreli is still calling the shots at Phoenixus AG, the drug company that used to be called Turing Pharmaceuticals AG. The Wall Street Journal goes inside the prison walls to see just what kind of life Shkreli is leading. In other pharmaceutical news: in a drug pricing hearing, Republicans warn against lawmakers undermining innovation; FDA issues a draft on naming features for biosimilar medicines; Anthem promises more transparency with its new PBM; and more.

from Kaiser Health News https://ift.tt/2VMIjp4